These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20338464)

  • 1. All research does not a guideline make!
    Moorthi RN; Moe SM; Drüeke T; Uhlig K
    Am J Kidney Dis; 2010 Apr; 55(4):631-4. PubMed ID: 20338464
    [No Abstract]   [Full Text] [Related]  

  • 2. [The new Kidney Disease: Improving Global Outcomes (KDIGO) guideline for the mineral and bone disorder associated with chronic kidney disease (MBD-CKD)].
    Drüeke TB
    Nephrol Ther; 2010 Jun; 6(3):149-50. PubMed ID: 20188646
    [No Abstract]   [Full Text] [Related]  

  • 3. [The French clinician's guide to the Kidney disease: Improving global outcomes (KDIGO) for chronic kidney disease-mineral and bone disorders (CKD-MBD)].
    Jean G; Chazot C
    Nephrol Ther; 2010 Jun; 6(3):151-7. PubMed ID: 20399169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphate binders: hold the calcium?
    Bushinsky DA
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):695-6. PubMed ID: 17699274
    [No Abstract]   [Full Text] [Related]  

  • 5. [Management of mineral and bone disease caused by chronic renal disease: what recommendations have contributed].
    Houillier P;
    Nephrol Ther; 2008 Sep; 4 Spec No 1():2-8, 15-9. PubMed ID: 19031626
    [No Abstract]   [Full Text] [Related]  

  • 6. KDIGO CKD-MBD Discussion forum: the Brazilian perspective.
    Moysés RM; Cancela AL; Gueiros JE; Barreto FC; Neves CL; Canziani ME; Oliveira RB; Jorgetti V; Carvalho AB
    J Bras Nefrol; 2010; 32(3):229-36. PubMed ID: 21103684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.
    National Kidney Foundation
    Am J Kidney Dis; 2003 Oct; 42(4 Suppl 3):S1-201. PubMed ID: 14520607
    [No Abstract]   [Full Text] [Related]  

  • 8. [Foreword. Brazilian clinical practice guidelines for mineral and bone disorders in chronic renal disease].
    de Carvalho AB
    J Bras Nefrol; 2011; 33(2):191. PubMed ID: 21789443
    [No Abstract]   [Full Text] [Related]  

  • 9. Expanding your nutritional knowledge.
    Greene JH; Harum P
    Nephrol News Issues; 2014 Jul; 26(8):19-20, 22. PubMed ID: 25141468
    [No Abstract]   [Full Text] [Related]  

  • 10. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units.
    Arenas MD; Alvarez-Ude F; Gil MT; Soriano A; Egea JJ; Millán I; Amoedo ML; Muray S; Carretón MA
    Nephrol Dial Transplant; 2006 Jun; 21(6):1663-8. PubMed ID: 16464885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The case against calcium-based phosphate binders.
    Moe SM; Chertow GM
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):697-703. PubMed ID: 17699275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hidden phosphorus in popular beverages.
    Murphy-Gutekunst L
    Nephrol Nurs J; 2005; 32(4):443-5. PubMed ID: 16180787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to K/DOQI bone metabolism guidelines.
    Smith DH; Johnson ES; Thorp ML; Yang X
    J Ren Nutr; 2009 Jul; 19(4):334-42. PubMed ID: 19539186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperphosphatemic renal osteodystrophy in a 4-year-old child].
    Siniavskaia OA; Zimina TS; Gol'tseva ZP
    Vopr Okhr Materin Det; 1965 Dec; 10(12):71-2. PubMed ID: 5873533
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic kidney disease-mineral and bone disorder KDIGO guidelines.
    Khwaja A
    Nephron Clin Pract; 2010; 116(1):c25-6. PubMed ID: 20460936
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of inorganic phosphorus analysis in clinical tests].
    Fujita T
    Nihon Rinsho; 1989 Dec; 48 Suppl():656-8. PubMed ID: 2621975
    [No Abstract]   [Full Text] [Related]  

  • 17. [K/DOQI clinical practice guidelines for bone metabolism and disease in CKD].
    Sakaguchi T; Akizawa T
    Clin Calcium; 2004 Sep; 14(9):9-14. PubMed ID: 15577103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Iodinated thyroid hormones and phosphocalcic metabolism].
    Bénichou C; Méry C
    Sem Hop; 1971 May; 47(25):1625-9. PubMed ID: 4327604
    [No Abstract]   [Full Text] [Related]  

  • 19. The calcium-phosphorus in guidelines for CKD-MBD.
    Yokoyama K
    Kidney Int; 2008 Jul; 74(2):245; author reply 246-7. PubMed ID: 18591947
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phosphorus-calcium metabolism and dietetic correction of its disorders in chronic kidney diseases in children].
    Ladodo KS; Spirichev VB; Kisteneva GS; Blazheevich NV; Kutafina EK
    Vopr Pitan; 1988; (1):24-8. PubMed ID: 3363911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.